GNH USA

Europe — EMA

Noradrenalin Laboratoire Aguettant (Noradrenaline Tartrate)

GNH USA supplies Noradrenalin Laboratoire Aguettant (Noradrenaline Tartrate), a vasopressor for hypotension, septic shock and cardiac arrest.

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline tartrate, the active ingredient in Noradrenalin Laboratoire Aguettant, is an adrenergic agonist presented as a sterile injectable solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock and cardiac arrest.

GNH USA supplies Noradrenalin Laboratoire Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global distribution to critical care facilities.

What is Noradrenaline Tartrate used for?

Noradrenalin Laboratoire Aguettant is used as a vasopressor to support circulatory function in critical care settings.

- Hypotension: restores arterial pressure and improves organ perfusion in patients with low blood pressure. - Septic shock: counteracts vasodilatory shock by increasing systemic vascular resistance. - Cardiac arrest: provides immediate pressor support during resuscitation efforts.

What are the side effects of Noradrenaline Tartrate?

Noradrenalin may cause a range of adverse reactions related to its potent vasoconstrictive activity.

Common Side Effects: - Tachycardia: increased heart rate due to reflex sympathetic activation. - Headache: result of elevated arterial pressure. - Anxiety or restlessness: central nervous system response to catecholamine surge. - Peripheral coldness: reduced blood flow to extremities.

Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure that can lead to end‑organ damage. - Cardiac arrhythmias: including ventricular tachycardia or fibrillation. - Tissue necrosis: ischemic injury at infusion sites if extravasation occurs.

What precautions apply to Noradrenaline Tartrate?

When using Noradrenalin, clinicians should observe several safety measures to minimize risks.

- Dose titration: adjust infusion rate to achieve target blood pressure while monitoring hemodynamics. - Cardiac monitoring: watch for arrhythmias or ischemia during therapy. - Peripheral perfusion: assess extremities for signs of ischemia. - Drug compatibility: avoid mixing with solutions that may precipitate. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenalin can interact with other agents that affect vascular tone or catecholamine metabolism.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension. - Indirect sympathomimetics (e.g., ephedrine): additive pressor effect leading to hypertensive crisis. - Beta‑blockers: may blunt desired increase in cardiac output.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: potential for increased blood pressure. - Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses. - Calcium channel blockers: possible attenuation of vasoconstrictive response.

Frequently asked questions

What is Noradrenalin Laboratoire Aguettant used for?+
Noradrenalin Laboratoire Aguettant is an intravenous vasopressor used in intensive‑care settings to treat severe hypotension, septic shock and cardiac arrest. By raising systemic vascular resistance, it helps restore adequate blood pressure and organ perfusion when conventional fluid resuscitation is insufficient.
How does noradrenaline tartrate work?+
Noradrenaline tartrate acts as a direct agonist at alpha‑1 adrenergic receptors on vascular smooth muscle, causing powerful vasoconstriction. This increases systemic vascular resistance and arterial pressure. It also stimulates beta‑1 receptors modestly, which can enhance cardiac contractility, together providing rapid pressor support.
What is the usual dose of Noradrenalin Laboratoire Aguettant?+
The dosing regimen for Noradrenalin Laboratoire Aguettant is individualized and must be determined by the treating physician. Dosage is typically expressed as a continuous intravenous infusion, titrated to achieve the desired blood pressure target while monitoring the patient’s response and side‑effects.
Is Noradrenalin Laboratoire Aguettant safe in pregnancy or breastfeeding?+
Safety data for noradrenaline in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be administered under close medical supervision.
How do I order Noradrenalin Laboratoire Aguettant from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Noradrenalin compare with other vasopressors?+
Noradrenalin is generally preferred over dopamine or phenylephrine for most forms of septic shock because it provides reliable arterial pressure elevation with fewer tachyarrhythmic effects. Unlike phenylephrine, it also offers modest beta‑1 activity, supporting cardiac output, while dopamine may cause more dose‑dependent side effects.
What are the storage and handling requirements for Noradrenalin Laboratoire Aguettant?+
The product must be stored refrigerated at 2‑8 °C, protected from light, and must never be frozen or shaken. Before use, inspect the vial for particulate matter and ensure the solution is at room temperature if required for administration, following aseptic technique.
How is Noradrenalin Laboratoire Aguettant administered?+
Noradrenalin is given as a continuous intravenous infusion, usually via a central venous catheter. The infusion is prepared in a compatible diluent, and the rate is titrated based on real‑time blood pressure measurements and patient response, with frequent hemodynamic monitoring.
What are the most serious risks associated with Noradrenalin Laboratoire Aguettant?+
The most critical risks include severe hypertension, cardiac arrhythmias such as ventricular tachycardia, and peripheral tissue ischemia that can progress to necrosis if extravasation occurs. Prompt recognition and dose adjustment are essential to mitigate these potentially life‑threatening complications.
Who should not receive Noradrenalin Laboratoire Aguettant?+
Contraindications include patients with pre‑existing severe hypertension, uncorrected hypovolemia, or peripheral vascular disease that predisposes to ischemia. Caution is also advised in individuals with recent myocardial infarction, uncontrolled tachyarrhythmias, or those receiving MAO inhibitors.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Laboratoire Aguettant
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU